(Bloomberg) -- Takeda Pharmaceutical is developing a drug to treat people who have novel coronavirus or are at high risk of contracting it, Dow Jones reports, citing Rajeev Venkayya, president of its vaccine business.
ADVERTISEMENT
- If tests are successful, Takeda will make the drug available in nine to 18 months.
ADVERTISEMENT
©2020 Bloomberg L.P.
RECOMMENDED FOR YOU
POPULAR
1
Serum Institute Says It Had Disclosed Rare Side Effects Of Covishield In 2021
2
Tata Power Announces Dividend Of Rs 2 Per Share For FY25
3
Your New Weatherman, Zomato
4
Bharat Forge Q4 Profit Jumps 78%, Shares Surge To Record High
5